Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
2 results
Filters applied: . Clear all
Page 1
Efficacy and Safety of TACE Combined with a Tyrosine Kinase Inhibitor for the Treatment of TACE-Refractory Hepatocellular Carcinoma: A Retrospective Comparative Study.
J Gastrointest Cancer. 2024 Mar 12. doi: 10.1007/s12029-024-01036-4. Online ahead of print.
J Gastrointest Cancer. 2024.
PMID: 38470522
Transarterial Chemoembolization Combined with Tyrosine Kinase Inhibitors Plus Immune Checkpoint Inhibitors Versus Tyrosine Kinase Inhibitors Plus Immune Checkpoint Inhibitors in Unresectable Hepatocellular Carcinoma with First- or Lower-Order Portal Vein Tumor Thrombosis.
Zhang JX, Cheng Y, Wei J, Fan WL, Liu J, Zhou CG, Liu S, Shi HB, Chu XY, Zheng WL, Zu QQ.
Zhang JX, et al.
Cardiovasc Intervent Radiol. 2024 Apr 26. doi: 10.1007/s00270-024-03724-x. Online ahead of print.
Cardiovasc Intervent Radiol. 2024.
PMID: 38671322
Item in Clipboard
Cite
Cite